EAN 2026 | Ovarian aging and long-term prognosis in women with multiple sclerosis

Mar Tintoré, MD, PhD, Vall d’Hebron University Hospital, Barcelona, Spain, discusses the findings of a study investigating the relationship between anti-müllerian hormone levels and long-term prognosis in women with multiple sclerosis (MS). Dr Tintoré highlights findings indicating that fertility does not seem to be reduced in patients with MS and that ovarian aging is not a direct driver of prognosis. This interview took place at the 12th Congress of the European Academy of Neurology (EAN) in Geneva, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.